A Taste Assessment of BMS-986165 in Healthy Participants
NCT03751228 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 9
Last updated 2019-10-01
Summary
The purpose of this study is to assess the taste characteristics of BMS-986165 formulations, alone and mixed, in order to develop a pediatric oral form of BMS-986165.
Conditions
- Healthy Participants
Interventions
- DRUG
-
BMS-986165
Swish and expectorate after tasting
- DRUG
-
Active Pharmaceutical Ingredient
Swish and expectorate after tasting
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 25 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-10-11
- Primary Completion
- 2018-11-26
- Completion
- 2018-11-26
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986337 When Taken by Mouth by Healthy Participants
NCT04550195 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Absorption, Metabolism, and Excretion of Orally Administered [14C]-BMS-986368 in Healthy Male Participants
NCT06227975 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Assessing the Drug Levels, Drug Effects, and Safety of BMS-986322 in Healthy Participants
NCT04175925 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of PF-06852231 in Healthy Subjects
NCT03217604 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Investigate Safety, Tolerability, And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult Volunteers
NCT00875628 ·Status: TERMINATED ·Phase: PHASE1
-
Single Dose Study To Compare Pharmacokinietics Of 3 Different Formulations Of PF-04991532 In Healthy Volunteers
NCT01351129 ·Status: COMPLETED ·Phase: PHASE1
-
Palatability of a Novel Oral Formulation of Prednsione
NCT02233959 ·Status: COMPLETED
-
A Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Multiple Oral Doses Of PF-04895162
NCT01691274 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effect of Food on the Drug Levels of BMS-986196 in Healthy Adult Participants
NCT06034899 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effect of Food on PC14586 in Healthy Volunteers and the PK of PC14586 in Healthy Japanese Volunteers
NCT05249348 ·Status: COMPLETED ·Phase: PHASE1
-
Taste Assessment Study of SHP429 in Healthy Adult Subjects
NCT02125292 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study to Determine the Safety and Pharmacokinetics of FP01 Lozenges in Healthy Volunteers
NCT01579526 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Drug Levels, Food, Formulation, and pH Effects on Relative Absorption of BMS-986465 and Its Active Derivative BMS-986464 in Healthy Participants
NCT06144697 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Assess the Absorption of a Single Dose of BMS-986205 in Healthy Volunteers When Administered as a Crushed Tablet Orally or Crushed Tablet Suspension Via Nasogastric Tube, as Compared to a Tablet
NCT03362411 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Trial to Investigate the Safety and Tolerability of PF-06412562
NCT01914796 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Dose Study in Healthy Volunteers to Assess Safety, Pharmacokinetics and Pharmacodynamics of PF 03882845
NCT00856258 ·Status: TERMINATED ·Phase: PHASE1
-
A Study In Healthy People To Investigate The Safety, Toleration And Time Course Of Blood Concentrations Of Multiple Doses Of PF-03654764, Given By Mouth
NCT00989391 ·Status: COMPLETED ·Phase: PHASE1
-
Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects
NCT01364441 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers
NCT00991016 ·Status: TERMINATED ·Phase: PHASE1
-
STUDY OF PF-07321332 IN HEALTHY PARTICIPANTS
NCT04756531 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers
NCT01379586 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects
NCT03351751 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Pharmacokinetics, Safety and Tolerability of PF-04965842 in Chinese Healthy Participants
NCT04099563 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study To Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects
NCT01616277 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Study to Assess the Safety, Tolerability and Pharmacokinetics(PK) of PF-06865571
NCT03092232 ·Status: COMPLETED ·Phase: PHASE1